Labcorp Other Current Assets 2010-2024 | LH

Labcorp other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Labcorp other current assets for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
  • Labcorp other current assets for 2023 were $0B, a NAN% decline from 2022.
  • Labcorp other current assets for 2022 were $0B, a NAN% decline from 2021.
  • Labcorp other current assets for 2021 were $0B, a NAN% decline from 2020.
Labcorp Annual Other Current Assets
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $34
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Labcorp Quarterly Other Current Assets
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30 $411
2018-03-31
2017-12-31 $34
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.857B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.818B 18.37
McKesson (MCK) United States $65.897B 18.13
Cardinal Health (CAH) United States $26.800B 14.83
West Pharmaceutical Services (WST) United States $22.575B 44.02
Cooper (COO) United States $22.126B 31.50
Align Technology (ALGN) United States $19.210B 37.11
Henry Schein (HSIC) United States $9.191B 16.83
Merit Medical Systems (MMSI) United States $5.834B 30.84
DENTSPLY SIRONA (XRAY) United States $5.453B 14.62
CONMED (CNMD) United States $2.323B 20.20
Patterson (PDCO) United States $1.962B 10.35
STAAR Surgical (STAA) United States $1.554B 70.22
Lifevantage (LFVN) United States $0.129B 17.76
Pro-Dex (PDEX) United States $0.093B 44.55